HSD3B7 and nonpapillary renal cell carcinoma: By incorporating multiple levels of experimental validation and corroborating our findings with existing literature, we provide a strong basis for the role of HSD3B7 in ccRCC, emphasizing its potential as both a prognostic marker and a therapeutic target.